Henry Ford Health · 7 hours ago
Research Study Coordinator III - Educator - Cancer Clinical and Translational Research Office - 40 Hours - Days
Henry Ford Health is the largest clinical research department at Henry Ford Health System, managing numerous trials focused on cancer. The Research Study Coordinator III-Educator will provide training and education to cancer clinical trial staff and support monitoring and auditing responsibilities.
BiotechnologyHealthcareHealth InsuranceHealth CareMedical
Responsibilities
Coordinating research projects within guides of regulatory compliance and/or Code of Federal Regulation
Provides technical support to Principal Investigators
Duties include but not limited to, interacting with both internal and external customers at all levels and oversight of recruitment and coordinating day-to-day operations of the study
Direct contact with potential and enrolled study participants expected. Provides other support as required
May work on multiple studies at any given time
Qualification
Required
Bachelor's degree in a scientific field, Psychology, Sociology, Anthropology, or related field
Three (3) years of relevant experience with at least two (2) years of research project coordination experience
SOCRA or ACRP and IATA certification required
Preferred
Strong knowledge of GCP and federal regulations
Clinical background
Cancer clinical research experience
Experience in developing and delivering educational content
Mentorship/preceptor experience
Company
Henry Ford Health
*Job seekers: please be aware of fraudulent job postings and phishing scams via LinkedIn.
H1B Sponsorship
Henry Ford Health has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (212)
2024 (156)
2023 (134)
2022 (159)
2021 (140)
2020 (153)
Funding
Current Stage
Late StageTotal Funding
$40.27MKey Investors
Mort Harris
2020-06-04Grant· $0.27M
2018-04-09Grant· $20M
2016-12-05Grant· $20M
Recent News
2025-11-07
Company data provided by crunchbase